Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.

@article{Lindgren2009ModelingTC,
  title={Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden.},
  author={Peter Lindgren and Pierre Geborek and Gis{\'e}la Kobelt},
  journal={International journal of technology assessment in health care},
  year={2009},
  volume={25 2},
  pages={181-9}
}
OBJECTIVES The aim of this study was to estimate the cost-effectiveness of rituximab in patients not responding adequately to the first tumor necrosis factor (TNF) inhibitor using a model constructed to predict resource consumption and health outcomes in a population-based registry of biological treatments in Southern Sweden (SSATG). METHODS The model was developed as a discrete event simulation model, using SSATG data for the years 1999-2007. The data set included 1,903 patients with… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 27 extracted citations

Similar Papers

Loading similar papers…